Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic
- PDF / 952,360 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 35 Downloads / 189 Views
RESEARCH ARTICLE
Open Access
Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic Songxiao Xu1,2†, Xiangdong Cheng2,3†, Zhiwen Pan1,2, Qian Song1,2, Yihong Wang4, Juan Xiong1,2, Yongyi Chen1,2, Fan Fan1,2, Jing Zhu1,2, Wanying Wu2,5, Xueying Deng2,6, Yanpin Yu2,6, Xiaohong Xu1,2, Wenhu Chen1,2, Tao Zhu2,7, Yang Yu2,8, Kaizhong Liu2,9, Guoliang Shao2,6, Ming Chen2,10* and Enyan Yu2,11*
Abstract Background: Due to the increased risk of viral infection and the severe shortage of medical resources during the pandemic of COVID-19, most hospitals in the epidemic areas significantly reduced non-emergency admissions and services, if not closed. As a result, it has been difficult to treat cancer patients on time, which adversely affects their prognosis. To address this problem, cancer centers must develop a strategic plan to manage both inpatients and outpatients during the pandemic, provide them with the necessary treatment, and at the same time prevent the spread of the virus among patients, visitors and medical staff. Methods: Based upon the epidemic situation in Zhejiang Province, China, the number of running non-emergency medical wards in the Zhejiang Cancer Hospital was gradually increased in a controlled manner. All staff of the hospital received COVID-19 preventive training and was provided with three different levels of protection according to the risks of their services. Only patients without a known history of SARS-CoV-2 contact were eligible to schedule an appointment. Body temperature was measured on all patients upon their arrival at the hospital. Chest CT image, blood cell counting and travel/contact history were investigated in patients with fever. Respiratory tract samples, such as sputum and throat swabs, from all patients, including those clinically suspected of SARS-CoV-2 infection, were collected for nucleic acid detection of SARS-CoV-2 before treatment. (Continued on next page)
* Correspondence: [email protected]; [email protected] † Songxiao Xu and Xiangdong Cheng contributed equally to this work. 2 Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China Full list of author information is available at the end of the article
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a
Data Loading...
